Alcohol Abuse: Clinical Trials

45 trials for Alcohol Abuse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

34 completed, 3 terminated, 2 recruiting, 2 unknown. 45 Phase 2, 7 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 245Completed 34, Terminated 3, Recruiting 2, Unknown 2, Withdrawn 2, Not yet recruiting 1, Suspended 1
Phase 17Completed 5, Unknown 1, Withdrawn 1
Phase 35Completed 2, Recruiting 1, Suspended 1, Unknown 1

Follow Alcohol Abuse: new trials by email Literature Review of Alcohol Abuse trials Research Report on Alcohol Abuse

Trials (filtered) newest first · largest first

All 45 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder
AFA-281 - Alcohol Abuse, Alcohol Abuse/addiction
Phase 2Not yet recruitingAfasci Inc362025-10-012024-11-29
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Psilocybin, Ketamine - Alcohol Use Disorder, Alcohol Dependence
Phase 2RecruitingUniversity of Iowa802025-06-122025-11-28
Motivational Interviewing Intervention For Risky Drinking Treatment Among Indigenous Population
Motivational interviewing - Alcohol Abuse
Phase 1 / Phase 2UnknownDepartment of Public Health Medicine, MARA University of Technology362024-10-012024-09-04
Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
Semaglutide Injectable Product, Placebo - Alcohol Abuse, Alcohol Addiction
Phase 2CompletedPsychiatric Centre Rigshospitalet1082023-06-132025-08-05
Efficacy of Simvastatin in Alcoholic Liver Fibrosis
Simvastatin 40mg - Liver Fibrosis, Alcohol Abuse
Phase 2 / Phase 3RecruitingAnna Cruceta902022-02-222024-12-04
CBD Oil for Reducing Emotional Impact of COVID-19
CBD Isolate, Full Spectrum CBD Oil, Broad-Spectrum CBD Oil - Anxiety Depression, Alcohol Abuse
Phase 2 / Phase 3SuspendedUniversity of Texas at Austin2002020-12-042023-11-22
Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies
Alcohol Moderation Mobile Application, Alcohol Moderation Drink Tracker - Alcohol Abuse, Alcohol Use Disorder
Phase 1 / Phase 2CompletedKent State University642020-02-052024-11-18
Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD
2mg Buprenex and 380mg Vivitrol, Placebo (SL pill qd, IM injection q4weeks) - Post Traumatic Stress Disorder, Alcohol Abuse
Phase 2TerminatedPharmacotherapies for Alcohol and Substance Use Disorders Alliance692019-05-202023-09-14
Buproprion for Binge Drinking
Bupropion, Placebo Oral Tablet - Alcohol Abuse
Phase 2CompletedUniversity of North Carolina, Chapel Hill422017-09-042020-08-26
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
Motivation Enhancement Therapy, Modified Behavioral Self-Control Therapy, Naltrexone - Alcohol-Related Disorders, Alcohol Drinking
Phase 1 / Phase 2CompletedNorthwell Health272017-01-012023-10-30
Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users
Tolcapone, Placebo - Alcohol Abuse, Impulsive Behavior
Phase 2CompletedJennifer Mitchell622016-10-012020-09-21
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
N-Acetylcysteine (NAC) Treatment, Cognitive Behavioral Therapy (CBT), Inactive Placebo Oral Capsule - Post Traumatic Stress Disorder (PTSD), Addiction
Phase 2CompletedMedical University of South Carolina1822016-10-012026-04-13
Delivering Treatment in DUI Programs to Reduce Alcohol-Related Disparities
Cognitive Behavioral Therapy, Usual Care - Alcohol Abuse
Phase 2CompletedRAND3512015-10-012020-04-10
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
Ondansetron, Placebo, BASICS Plus - Alcohol Abuse, Alcoholism
Phase 2TerminatedUniversity of Maryland, Baltimore742015-09-012023-05-26
Mifepristone Treatment of Alcohol Use Disorder
Mifepristone 1200 mg daily, Standardized behavioral therapy, Placebo - Alcohol Dependence, Alcohol Use Disorders
Phase 2CompletedThe Scripps Research Institute1032014-09-012022-10-06
Use of Kudzu Extract in the Study of Its Ability to Reduce Alcohol Drinking in Treatment Seeking Alcohol Dependent Persons
Kudzu extract, Placebo, Medical Management - Alcohol Abuse, Alcohol Dependence
Phase 2WithdrawnMclean Hospital2014-03-012015-10-07
ABT-436 for Alcohol Dependence
ABT-436, Matched Placebo - Sugar Pill - Alcohol Dependence, Alcohol Abuse
Phase 2CompletedNational Institute on Alcohol Abuse and Alcoholism (NIAAA)1502013-02-012017-04-04
Carisbamate as a Potential Treatment for Alcohol Dependence
Carisbamate, Placebo - Alcohol Dependence, Alcohol Abuse
Phase 1 / Phase 2CompletedBaylor College of Medicine112013-02-012021-03-02
Varenicline Treatment of Alcohol Dependence in Smokers
Varenicline - Alcoholism, Alcohol Abuse
Phase 2CompletedYale University1312012-09-012020-03-06
cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use
Computer Screening, Brief Intervention, Referral toTreatment - Tobacco Abuse, Alcohol Abuse
Phase 1 / Phase 2WithdrawnBoston Children's Hospital2011-09-012016-10-07

Showing 20 of 45. Sign in to see all of them.

Narrower conditions

Alcoholism (45)  ·  Substance-Related Disorders (14)  ·  Alcohol Drinking (5)  ·  Depression (4)  ·  Stress Disorders, Post-Traumatic (4)  ·  Alcohol-Related Disorders (3)  ·  Behavior, Addictive (3)  ·  Marijuana Abuse (3)  ·  Anxiety Disorders (2)  ·  Binge Drinking (2)  ·  Conduct Disorder (2)  ·  Panic Disorder (2)  ·  Patient Compliance (2)  ·  Smoking (2)  ·  Tobacco Use (2)

Broader conditions

Chemically-Induced Disorders (45)  ·  Mental Disorders (44)  ·  Alcohol-Related Disorders (42)  ·  Substance-Related Disorders (31)  ·  Behavior (17)  ·  Drinking Behavior (7)  ·  Behavioral Symptoms (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Stress Disorders, Traumatic (4)  ·  Trauma and Stressor Related Disorders (4)  ·  Compulsive Behavior (3)  ·  Health Behavior (3)  ·  Impulsive Behavior (3)  ·  Pathologic Processes (3)  ·  Patient Acceptance of Health Care (3)

Interventions

Sugars (5)  ·  Crisis Intervention (4)  ·  Counseling (3)  ·  Ethanol (3)  ·  Motivational Interviewing (3)  ·  Cognitive Behavioral Therapy (2)  ·  Naltrexone (2)  ·  Ondansetron (2)  ·  Practice Management, Medical (2)  ·  Quetiapine Fumarate (2)  ·  Acetylcysteine (1)  ·  Buprenorphine (1)  ·  Bupropion (1)  ·  Citalopram (1)  ·  Contracts (1)

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA) (3)  ·  Boston Children's Hospital (2)  ·  Boston Medical Center (2)  ·  King's College London (2)  ·  Mclean Hospital (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Yale University (2)  ·  Afasci Inc (1)  ·  Anna Cruceta (1)  ·  Baylor College of Medicine (1)  ·  Department of Public Health Medicine, MARA University of Technology (1)  ·  Duke University (1)  ·  Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH (1)  ·  Jennifer Mitchell (1)  ·  Johns Hopkins University (1)

Countries

United States (37)  ·  United Kingdom (2)  ·  Denmark (1)  ·  Germany (1)  ·  Malaysia (1)  ·  Spain (1)

Top investigators

John R. Knight, MD (2)  ·  Allen Zweben, PhD (1)  ·  Anders Fink-Jensen, MD, DMSc (1)  ·  Bankole Johnson, DSc,MD,PhD (1)  ·  Barbara J. Mason, Ph.D (1)  ·  Bernhard Croissant, MD PhD (1)  ·  David M. Penetar, Ph.D. (1)  ·  David M. Penetar, PhD (1)  ·  Denise A. Hien, PhD (1)  ·  Denise D Walker, PhD (1)  ·  Domenic A Ciraulo, MD (1)  ·  Edwin Boudreaux, PhD (1)  ·  James C Garbutt (1)  ·  James C Garbutt, M.D. (1)  ·  Jennifer Mitchell, PhD (1)

Results publications

PMID 20732631, PMID 33605440, PMID 20048226, PMID 20105415, PMID 20598843, PMID 20869813, PMID 21443297, PMID 21950727, PMID 22795046, PMID 23122489, PMID 23186301, PMID 23344135, PMID 24447885, PMID 25427171, PMID 25622199, PMID 25909320, PMID 26011508, PMID 26241598, PMID 26422415, PMID 26542471, PMID 26881449, PMID 27036221, PMID 27627782, PMID 27936818, PMID 28270105, PMID 28461283, PMID 29261824, PMID 30817018, PMID 30865304, PMID 31894995, PMID 32608505, PMID 32617646, PMID 32963470, PMID 33654213, PMID 39779270, PMID 40123107, PMID 40824526, PMID 40875537, PMID 42070571

NIH funding

P60AA013759 (2), P20AA017839 (1), R01AA010522 (1), R01AA012178 (1), R01AA012518 (1), R01AA013957 (1), R01AA014341 (1), R01AA015923 (1), R01AA018896 (1), R01AA020388 (1), R01AA025086 (1), R01DA019135 (1), R21AA017503 (1), R21AA025186 (1), R34AA024589 (1)